Forums, blogs, and more can spark innovation.
We recently added a callout to the end of our peer-reviewed articles, but we're not sure you've seen it. The red icon asks for your input on the published paper: What would you have done differently if it had been your experiment, your process, or your equipment? We, and the authors of the research papers herein, would like your feedback.
Angie Drakulich
We welcome you to email your thoughts to us at ptweb@advanstar.com regarding any peer-reviewed papers, or any articles for that matter, that appear in the magazine or on our website and we'll post your comments in a special online section at the end of the appropriate article. Our goal is to encourage more discussion among industry peers to promote the exchange of ideas and ultimately, innovation.
In fact, we just launched a call for nominations for the 2008 Innovations in Pharma Science Awards, which will honor achievements in the pharmaceutical sciences. Check out pharmtech.com/Innovations to nominate your company's work in one of five areas: drug delivery, formulation, dosage forms, pharmaceutical analysis, and API synthesis. The winners will be announced in the December issue.
PharmTech also has a daily blog, blog.pharmtech.com, where you can exchange ideas with the editors and experts by commenting on current posts, or adding your own post. What better way is there to increase your industry knowledge and advance your on-the-job skills than to talk to those people doing the same thing you're doing? So join us online and let's get talking.
Angie Drakulich is the managing editor of Pharmaceutical Technology, adrakulich@advanstar.com
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.